A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2030

Conditions
Sexual DysfunctionStem Cell Transplant ComplicationsBone Marrow Transplant Complications
Interventions
BEHAVIORAL

SHIFT Intervention Group

Participants assigned to SHIFT will meet with their HCT clinician for a brief medical examination to assess the need for medications for erectile dysfunction, vaginal atrophy, or genital graft-versus-host disease; and start using SHIFT at their desired pace over 8 weeks to complete five modules.

BEHAVIORAL

Enhanced Usual Care Group

Participants assigned to the enhanced usual care group will meet with their HCT clinician for a brief medical examination to assess the need for medications for erectile dysfunction, vaginal atrophy, or genital graft-versus-host disease; and maybe referred to a psychologist, urologist, or gynecologist at the participants' request or at the discretion of the HCT clinician.

Trial Locations (3)

19111

NOT_YET_RECRUITING

Fox Chase Cancer Center, Philadelphia

33124

NOT_YET_RECRUITING

University of Miami, Coral Gables

02114

RECRUITING

Massachusetts General Hospital (MGH), Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER